550 related articles for article (PubMed ID: 16316827)
21. Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: implications for HIV immunopathogenesis.
Liu J; Roederer M
Cytometry A; 2007 Feb; 71(2):94-104. PubMed ID: 17200952
[TBL] [Abstract][Full Text] [Related]
22. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
23. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.
Naoe M; Ogawa Y; Takeshita K; Morita J; Iwamoto S; Miyazaki A; Yoshida H
Int J Urol; 2007 Jun; 14(6):532-8; discussion 538. PubMed ID: 17593099
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic cellular mediators of the immune response to neoplasia: a review.
Khavari P
Yale J Biol Med; 1987; 60(5):409-19. PubMed ID: 3321723
[TBL] [Abstract][Full Text] [Related]
26. [Cytotoxic cells of the NK type - their characteristics and role in anti-neoplastic immunity].
Janiak M; Lipski S
Postepy Hig Med Dosw; 1982; 36(1-3):95-131. PubMed ID: 6763997
[No Abstract] [Full Text] [Related]
27. Neuroendocrine regulation and tumor immunity.
Toni R; Mirandola P; Gobbi G; Vitale M
Eur J Histochem; 2007; 51 Suppl 1():133-8. PubMed ID: 17703604
[TBL] [Abstract][Full Text] [Related]
28. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
29. NK and NKT cell functions in immunosenescence.
Mocchegiani E; Malavolta M
Aging Cell; 2004 Aug; 3(4):177-84. PubMed ID: 15268751
[TBL] [Abstract][Full Text] [Related]
30. The 'kiss of death' by dendritic cells to cancer cells.
Chan CW; Housseau F
Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
[TBL] [Abstract][Full Text] [Related]
31. The role of T lymphocytes in the immunotherapy of tumours.
Brondz BD; Balashov KE
Biomed Sci; 1991; 2(5):441-9. PubMed ID: 1840832
[TBL] [Abstract][Full Text] [Related]
32. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
[TBL] [Abstract][Full Text] [Related]
33. [Types of cellular antitumor cytotoxicity].
Lomakin MS; Maĭskiĭ IN
Vopr Onkol; 1988; 34(12):1422-32. PubMed ID: 2975420
[No Abstract] [Full Text] [Related]
34. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands.
Chen Y; Shi Y; Cheng H; An YQ; Gao GF
IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182
[TBL] [Abstract][Full Text] [Related]
35. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
von Lilienfeld-Toal M; Nattermann J; Feldmann G; Sievers E; Frank S; Strehl J; Schmidt-Wolf IG
Clin Exp Immunol; 2006 Jun; 144(3):528-33. PubMed ID: 16734623
[TBL] [Abstract][Full Text] [Related]
36. NK cell-based cancer immunotherapy.
Stagg J; Smyth MJ
Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
[TBL] [Abstract][Full Text] [Related]
37. Cancer evolution and immunity in a rat colorectal carcinogenesis model.
Vannucci L; Fiserova A; Horvath O; Rossmann P; Mosca F; Pospisil M
Int J Oncol; 2004 Oct; 25(4):973-81. PubMed ID: 15375547
[TBL] [Abstract][Full Text] [Related]
38. NK cells: innate immunity against hematological malignancies?
Costello RT; Fauriat C; Sivori S; Marcenaro E; Olive D
Trends Immunol; 2004 Jun; 25(6):328-33. PubMed ID: 15145323
[TBL] [Abstract][Full Text] [Related]
39. gammadelta T cells: a new frontier for immunotherapy?
Lamb LS; Lopez RD
Biol Blood Marrow Transplant; 2005 Mar; 11(3):161-8. PubMed ID: 15744234
[TBL] [Abstract][Full Text] [Related]
40. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
Wrobel P; Shojaei H; Schittek B; Gieseler F; Wollenberg B; Kalthoff H; Kabelitz D; Wesch D
Scand J Immunol; 2007; 66(2-3):320-8. PubMed ID: 17635809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
